Amy Jacob

Antony Loebel, MD, Executive Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc. provided invaluable insight on the first placebo-controlled trial for patients with Major Depressive Disorder with mixed features.

Edward Damiano, PhD, Professor of Biomedical Engineering, Boston University shared his 2013-2015 research results surrounding the acclaimed bionic pancreas at the 24th American Association of Clinical Endocrinologists Nashville, TN.

Henry Nasrallah, MD, Sydney W. Souers Endowed Chair, Professor & Chairman, Department of Neurology & Psychiatry, Saint Louis University School of Medicine introduced his research surrounding Parkinson's Disease Psychosis, often considered a new battle field for many psychiatrists.

Timothy Garvey, MD, FACE, Professor at the University of Alabama at Birmingham, and Chair of the AACE Obesity Scientific Committee, provided an overview of the AACE Module and Tool Kit for Obesity Medicine at the 24th Annual Scientific & Clinical Congress in Nashville, TN.

Georgios Grammatikos, MD, commented at The International Liver Congress 2015 in Vienna, Austria, "We do think in liver diseases we show the opening of this topic in chronic hepatopathy and we do believe mass spectrometric methods -- in order to identify the levels of single lipids-- as one method of the future."

Researchers from Canada recently published an updated set of guidelines for patients afflicted with mild to severe Ulcerative colitis (UC).

Relaxation responses physiologic states of deep rest induced by practices such as meditation, yoga, and prayer were reported to positively trigger symptom improvement and gene expression changes within patients afflicted with gastrointestinal disorders like irritable bowel syndrome and inflammatory bowel disease.

Interleukin-17, one of the T-helper 1 (Th17) subtypes had been reported to be a significant trigger for plaque psoriasis however the specific contribution of each cytokine group still remains questionable.

Approximately 1 in 6 patients suffering from gastrointestinal stromal tumors (GIST) are likely to develop malignant cancers before or after diagnosis, according to the inaugural population-based study recently conducted by researchers at the UC San Diego School of Medicine.

Lise Lotte Gluud, MD, DmSc, shared some of the best practices she and her colleagues learned through their own research at The International Liver Congress 2015 Vienna, Austria.

Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, discussed his hope for hepatologists to better understand the mechanisms that lead from fatty liver to steatohepatitis and subsequently from steatohepatitis to cirrhosis at The International Liver Congress 2015.

In this video interview, Camille Barrault, MD, spoke about the implications her work with baclofen could have for the future of liver disease research at The International Liver Congress 2015, Vienna, Austria.

Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, shared valuable insight regarding chronic alcoholic demographics and biomarkers on the horizon at The International Liver Congress 2015.

Video Interview: Camille Barrault, MD discussed how her experiences with alcohol dependent patients correlated with her team's current research at The International Liver Congress 2015, Vienna, Austria.

Video Interview: Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, spoke about several drug candidates under review working to improve outcomes of liver blood tests at The International Liver Congress 2015, Vienna, Austria.

In this video interview, Palak Trivedi, BSc, MBBS, MRCP, from the University of Birmingham Centre for Liver Research, United Kingdom, discussed the implications his research findings have for IBD patients at The International Liver Congress 2015 in Vienna, Austria.

Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, shared his fascination with the enigma that is primary sclerosing cholangitis.

Soligenix, Inc., a late-stage biopharmaceutical company, recently announced that the US Food and Drug Administration (FDA) authorized a pivotal Phase 3 clinical trial to assess the efficacy of novel drug SGX203, a pediatric Crohn's disease (CD) therapy.

The first guttate psoriasis (GP) episode, which is often triggered by an acute infection such as streptococcal pharyngitis, often results in patients developing chronic plaque psoriasis, according to research presented at the 73rd American Academy of Dermatology Annual Meeting.

Patients with plaque psoriasis often experience clear improvement in their skin conditions after undergoing tonsillectomy.

Norovirus, the leading cause of acute gastroenteritis in adults and children in the US (aka "stomach flu" marked by vomiting and diarrhea) could potentially be spread from canines to humans, according to research published in the Journal of Clinical Microbiology.

Inflammatory Bowel Disease (IBD) has successfully made the exclusive list of conditions New York State deems appropriate to be treated with medical marijuana.

Cancer Research UK had confirmed the steady increase in malignant melanoma incidences among individuals 65 years and older.

Bühlmann, a global calprotectin laboratory headquartered in Switzerland, announced Wednesday the launch of IBDoc®, the first at home in-vitro diagnostic test to measure the fecal inflammation marker calprotectin in patients with inflammatory bowel disease (IBD), Crohn's disease (CD), and Ulcerative colitis (UC).

Public health officials in the US have reported a series of outbreaks of disease caused by the introduction of a multi-drug-resistant strain of the bacteria Shigella by international travelers.

Joseph V. Pergolizzi, MD discusses the integral role his background in physical chemistry and drug development plays in pain medicine research.

The US Food and Drug Administration (FDA) announced Monday its approval of the Gastric Emptying Breath Test, a new non-invasive test to help diagnosis-delayed gastric emptying, otherwise known as gastroparesis.

Patients suffering from inflammatory bowel disease (IBD) who also have urinary calculi were recently found more likely to experience urinary tract infections, renal failure, and sepsis.

Non-alcoholic steatohepatitis (NASH), deemed a more serious form of non-alcoholic fatty liver disease (NAFLD) that can develop into liver fibrosis and cirrhosis, has been linked to the liver cancer-spiraling leaky intestinal wall, according to research in Cellular and Molecular Gastroenterology and Hepatology.

Symptoms of delayed growth, weight loss, failure to gain weight, or persistent stomach pain coupled with diarrhea or bloody stools in children are often linked to undiagnosed inflammatory bowel disease (IBD), particularly Crohn's disease (CD).